Goose, it is fun to think about where we can go with this amazing molecule. Of course that's assuming that we are efficacious in COVID, Cancer, NAsh, etc. But the early Indications look promising.

Now, let me blow your mind. It won't take ten years.

The trajectory of big pharma is slowed by developing or acquiring new indications. All we have to do is run trials and price them.

Once we have revenue from covid, we will start them in rapid succession.

We could be there in 3-5 years.